Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2054766 | International Journal for Parasitology: Drugs and Drug Resistance | 2011 | 12 Pages |
Many of the anthelmintic drugs in use today act on the nematode nervous system. Ion channel targets have some obvious advantages. They tend to act quickly, which means that they will clear many infections rapidly. They produce very obvious effects on the worms, typically paralyzing them, and these effects are suitable for use in rapid and high-throughput assays. Many of the ion channels and enzymes targeted can also be incorporated into such assays. The macrocyclic lactones bind to an allosteric site on glutamate-gated chloride channels, either directly activating the channel or enhancing the effect of the normal agonist, glutamate. Many old and new anthelmintics, including tribendimidine and the amino-acetonitrile derivatives, act as agonists at nicotinic acetylcholine receptors; derquantel is an antagonist at these receptors. Nematodes express many different types of nicotinic receptor and this diversity means that they are likely to remain important targets for the foreseeable future. Emodepside may have multiple effects, affecting both a potassium channel and a pre-synaptic G protein-coupled receptor; although few other current drugs act at such targets, this example indicates that they may be more important in the future. The nematode nervous system contains many other ion channels and receptors that have not so far been exploited in worm control but which should be explored in the development of effective new compounds.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slideHighlights► Most current anthelmintics act on the nematode nervous system. ► Nematodes express a large variety of ion channels and receptors. ► Glutamate-gated chloride channels and nicotinic receptors are key drug targets. ► Many other receptor and ion channel families have potential.